Literature DB >> 16911396

Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo.

Ahu Birol, Ucler Kisa, Gulcan Saylam Kurtipek, Fatma Kara, Mukadder Kocak, Emel Erkek, Osman Caglayan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16911396     DOI： 10.1111/j.1365-4632.2006.02744.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  19 in total

1.  Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.

Authors:  Mehdi Rashighi; John E Harris
Journal:  Ann Transl Med       Date:  2015-12

2.  Methotrexate for the treatment of generalized vitiligo.

Authors:  Khalid Alghamdi; Huma Khurrum
Journal:  Saudi Pharm J       Date:  2013-10       Impact factor: 4.330

3.  Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin.

Authors:  Ola Ahmed Bakry; Magda Mostafa Hagag; Mona Abd El Halim Kandil; Wafaa Ahmed Shehata
Journal:  J Clin Diagn Res       Date:  2016-12-01

4.  Vitiligo and alopecia areata: apples and oranges?

Authors:  John E Harris
Journal:  Exp Dermatol       Date:  2013-12       Impact factor: 3.960

Review 5.  Participation of keratinocyte- and fibroblast-derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders.

Authors:  Parth R Upadhyay; Tina Ho; Zalfa A Abdel-Malek
Journal:  Pigment Cell Melanoma Res       Date:  2021-05-24       Impact factor: 4.693

6.  The role of cytokines in the pathomechanism of cutaneous disorders.

Authors:  Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2012-03       Impact factor: 1.494

7.  Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.

Authors:  Siavash Toosi; Seth J Orlow; Prashiela Manga
Journal:  J Invest Dermatol       Date:  2012-06-14       Impact factor: 8.551

Review 8.  Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.

Authors:  K C Webb; R Tung; L S Winterfield; A B Gottlieb; J M Eby; S W Henning; I C Le Poole
Journal:  Br J Dermatol       Date:  2015-08-25       Impact factor: 9.302

9.  Vitiligo: a possible model of degenerative diseases.

Authors:  Barbara Bellei; Angela Pitisci; Monica Ottaviani; Matteo Ludovici; Carlo Cota; Fabiola Luzi; Maria Lucia Dell'Anna; Mauro Picardo
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Role of keratinocytes in the development of vitiligo.

Authors:  Ai-Young Lee
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.